Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (56.201)

141

Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma

enthalten in: Clinical genitourinary cancer | 2024

von Grünwald, V. | Larkin, J. | Puente, J. | +2

142

Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma : a retrospective analysis

enthalten in: BMC cancer | 2024

von Cirillo, A. | Marinelli, D. | Romeo, U. | +14

ErratumIn: BMC Cancer. 2024 Apr 17;24(1):487. - PMID 38632499

143

Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022 : an interim analysis using the French JIR cohort database

enthalten in: Arthritis research & therapy | 2024

von Koné-Paut, I. | Georgin-Lavialle, S. | Belot, A. | +5

144

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus : A Post Hoc Analysis of the EXCEED-BHS3 Trial

enthalten in: International journal of molecular sciences | 2024

von Bonilha, I. | Gomes, �. | Carmo, H. | +13

145

Histopathologic features of biologic therapy nonresponders in chronic rhinosinusitis with nasal polyposis

enthalten in: International forum of allergy & rhinology | 2024

von Baird, A. | Masliah, J. | Filip, P. | +8

146

A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer

enthalten in: Cancer research and treatment | 2024

von Lee, K. | Han, S. | Kim, T. | +13

147

Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Ohama, H. | Hiraoka, A. | Tada, T. | +42

148

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma : a phase 1/2 trial

enthalten in: Nature medicine | 2024

von Yarchoan, M. | Gane, E. | Marron, T. | +17

149

Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma : a prospective phaseⅡstudy

enthalten in: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery | 2024

von Chen, X. | Xie, Z. | Lu, H. | +2

150

Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2-expressing salivary gland carcinoma : a pooled analysis of two phase I studies

enthalten in: Japanese journal of clinical oncology | 2024

von Takahashi, S. | Bando, H. | Kinoshita, I. | +9